Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

8 Stocks and ETFs Your Financial Advisor Is Buying Right Now

Page 1 of 2

What are the best stocks to buy right now? We try to answer this question every day by tracking the moves of smart money and buyside analysts. Sell side analysts usually aren’t independent and their published opinions may be significantly different from their true opinions. This usually isn’t the case with buy side analysts. One of the sources we use to identify investment ideas is checking out the list of stocks financial advisors are searching. Investing Channel’s Intuition publishes a weekly report called Trackstar. According to the latest report covering the February 28th-March 5th period financial advisors’ number one target is Colgate Palmolive Co. (NYSE:CL).

Colgate-Palmolive Co. (CL)  is a low volatility stock that has been trading between $50 and $70 in the last 12 months. It has a dividend yield of slightly north of 2.2%. The stock is clearly a flight-to-safety play gaining about 2.5% this year. I glanced over the key statistics of Colgate-Palmolive Co and didn’t really find the stock underpriced. CL’s forward price-earnings ratio is north of 22. It may be a good alternative to long-term bonds but it isn’t the type of stock that can double or triple your money in the next 10 years. Hedge funds don’t like the stock that much. They aren’t short but collectively own only about 3% of its outstanding shares of Colgate-Palmolive.

Intrexon Corporation (NYSE:XON) is the second most popular stock among financial advisors in Trackstar’s list. This small biotech stock garnered more attention than tech giants like Apple and Facebook for an interesting reason. You can read the details here. Intrexon Corporation is one of the best performing stocks this year gaining about 25% year-to-date.

One of the most popular sectors among financial advisors is technology. The top three technology stocks among financial advisors are Apple Inc (AAPL), Netflix (NFLX) and Facebook (FB). Personally I don’t like Apple as a long-term or short-term investment. Before getting into the details, let’s first explain why financial advisors like NFLX and FB. Both of these stocks were among the best performing stocks in 2015 and still garner a lot of attention due to this fact. Nearly one out of every 5 hedge funds has a long position in Facebook.

Hedge funds love Netflix even more based on their 15% economic interest in the stock. However, this doesn’t mean that these two stocks will be good picks in 2016. I should warn you that there are a lot of hedge funds and investors who are very skeptical about Netflix’s surge. The short interest in the stock is also nearly 15%. Here is what David Einhorn said about Netflix last year:

David Einhorn
David Einhorn
Greenlight Capital

On April 15 after the close, Netflix (NFLX) announced its results for the first quarter and conducted a conference call. NFLX shares had already risen 39% in 2015 and were trading at more than 100x 2016 estimates with analysts expecting adjusted earnings for the quarter of $0.63. NFLX achieved just $0.36. Prior to the call, the June quarter consensus stood at $0.86; by the next morning consensus was $0.30. All told, analysts slashed estimates for the next three years. If you’d told us the news in advance, we’d have guessed it was going to be a bad day for NFLX holders, but apparently Red Ink is the New Black. The shares opened the next morning 12% higher and never looked back. By the end of the quarter, the shares had almost doubled for the year, making NFLX the best performing stock in the S&P 500 by far. Why did the stock react that way? Cynically: if it soared on bad news, imagine what it would do with good news. Practically: NFLX changed its story and pushed its promises into the distant future, with grand hopes for the decade starting in 2020. It transitioned from being a company judged by how much it earns into a company judged by how much it spends. Whether the spending proves successful won’t be known during the investment horizon of most NFLX shareholders. In today’s market, the best performing stocks are companies with exciting stories where accountability is in the distant future.”

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!